As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Generic Drugs Market: By Application: CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Others; By Drug Delivery; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Generic Drugs Market Outlook

The global generic drugs market size reached a value of almost USD 370 billion in the year 2020. The market is further expected to grow at a CAGR of 5.5% between 2021 and 2026 to reach a value of almost USD 510.2 billion by 2026.

 

Global Generic Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global generic drugs market is driven by the rising cardiometabolic risk factors across the globe. The United States is the leading regional market. This can be attributed to the implementation of rigorous reviews by the numerous regulatory bodies to ensure optimum standards during the manufacturing of these drugs, further aiding the market growth in the region.

 

Properties and Applications

Generic drugs are referred to as the bioequivalent of brand-name drugs on the basis of safety, strength, quality, stability, impact, intended use, dosage form, and the route of administration. These drugs are established to be safe and effective just as their already marketed brand-name formulation. Generic drug manufacturers are not required to invest in drug research or drug development and marketing, which makes these medicines cost-effective, thereby contributing to their widespread preference.

 

Generic Drugs Market by Drug Delivery

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The generic drugs market is segmented on the basis of application into:

  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Among all of these, cardiovascular diseases represent the largest segment in the market.

On the basis of drug delivery, the industry is divided into:

  • Oral
  • Injectables   
  • Dermal/Topical
  • Inhalers

Oral generic drugs at present account for a majority of the total market share.

On the basis of distribution channel, the industry is bifurcated into:

  • Retail Pharmacies
  • Hospital Pharmacies

Out of these, retail pharmacies represent a clear dominance in the global generic drugs market.

The report also covers the regional markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Generic Drugs Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global generic drugs market is driven by the significant rise in the cardiometabolic risk factors among the population. In addition to this, due to various factors, such as changing dietary patterns, sedentary lifestyles, and hectic working schedules, there is a growing prevalence of diabetes, dyslipidaemia, hypertension, metabolic syndrome, and obesity. This has resulted in a considerable rise in the uptake of medicines, thereby accelerating the growth of the industry.

The global generic drugs market is further enhanced by the huge costs related to the medication of various chronic and lifestyle diseases, which have led to the increase in the consumer inclination toward affordable variants, further boosting the demand. Apart from this, the patent expiration of crucial blockbuster drugs, in conjunction with multiple favourable initiatives undertaken by the governments of several countries to promote the usage of generic drugs, is anticipated to propel the industry growth. Numerous regulatory bodies are implementing rigorous reviews to ensure optimum standards during the manufacturing of these drugs.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the global generic drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Generic Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Generic Drugs Historical Market (2016-2020) 
    8.3    Global Generic Drugs Market Forecast (2021-2026)
    8.4    Global Generic Drugs Market by Application
        8.4.1    CNS
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Cardiovascular
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Dermatology
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Genitourinary/Hormonal
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Respiratory
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
        8.4.6    Rheumatology
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
        8.4.7    Diabetes
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2016-2020)
            8.4.7.3    Forecast Trend (2021-2026)
        8.4.8    Oncology
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2016-2020)
            8.4.8.3    Forecast Trend (2021-2026)
        8.4.9    Others
    8.5    Global Generic Drugs Market by Drug Delivery
        8.5.1    Oral
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Injectables   
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Dermal/Topical
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Inhalers
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
    8.6    Global Generic Drugs Market by Distribution Channel
        8.6.1    Retail Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Hospital Pharmacies   
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
    8.7    Global Generic Drugs Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
            10.1.1    Strengths
            10.1.2    Weaknesses
            10.1.3    Opportunities
            10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
            10.2.1    Supplier’s Power
            10.2.2    Buyer’s Power
            10.2.3    Threat of New Entrants
            10.2.4    Degree of Rivalry
            10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Project Economics
    12.1    Capital Cost of the Project
    12.2    Techno-Economic Parameters
    12.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    12.4    Taxation and Depreciation
    12.5    Income Projections
    12.6    Expenditure Projections
    12.7    Financial Analysis
    12.8    Profit Analysis
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Company Profiles
        13.3.1    Teva Pharmaceutical Industries Ltd.
            13.3.1.1    Company Overview
            13.3.1.2    Product Portfolio
            13.3.1.3    Demographic Reach and Achievements
            13.3.1.4    Certifications
        13.3.2    Mylan N.V.
            13.3.2.1    Company Overview
            13.3.2.2    Product Portfolio
            13.3.2.3    Demographic Reach and Achievements
            13.3.2.4    Certifications
        13.3.3    Novartis AG
            13.3.3.1    Company Overview
            13.3.3.2    Product Portfolio
            13.3.3.3    Demographic Reach and Achievements
            13.3.3.4    Certifications
        13.3.4    Sun Pharmaceutical Industries Ltd.
            13.3.4.1    Company Overview
            13.3.4.2    Product Portfolio
            13.3.4.3    Demographic Reach and Achievements
            13.3.4.4    Certifications
        13.3.5    Fresenius Kabi AG
            13.3.5.1    Company Overview
            13.3.5.2    Product Portfolio
            13.3.5.3    Demographic Reach and Achievements
            13.3.5.4    Certifications
        13.3.6    Others
14    Industry Events and Developments


List of Figures and Tables

1.    Global Generic Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Generic Drugs Historical Market: Breakup by Application (USD Billion), 2016-2020
3.    Global Generic Drugs Market Forecast: Breakup by Application (USD Billion), 2021-2026
4.    Global Generic Drugs Historical Market: Breakup by Drug Delivery (USD Billion), 2016-2020
5.    Global Generic Drugs Market Forecast: Breakup by Drug Delivery (USD Billion), 2021-2026
6.    Global Generic Drugs Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
7.    Global Generic Drugs Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
8.    Global Generic Drugs Historical Market: Breakup by Region (USD Billion), 2016-2020
9.    Global Generic Drugs Market Forecast: Breakup by Region (USD Billion), 2021-2026
10.    North America Generic Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    North America Generic Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Europe Generic Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Europe Generic Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Asia Pacific Generic Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Asia Pacific Generic Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Latin America Generic Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Latin America Generic Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Middle East and Africa Generic Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Middle East and Africa Generic Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Global Generic Drugs Market Structure

Key Questions Answered in the Report

The global generic drugs market reached a value of USD 370 billion in 2020. 

The industry is projected to grow at a CAGR of nearly 5.5% in the forecast period of 2021-2026.

The industry is estimated to reach a value of about USD 510.2 billion by 2026.

The major drivers of the industry include rising disposable incomes, increasing population, rising cardiometabolic risk factors, and the implementation of rigorous reviews by the numerous regulatory bodies to ensure optimum standards during the production of these drugs.

Various favourable initiatives undertaken by the governments of multiple countries is expected to be a key trend guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.

Cardiovascular disease is the dominant application segment in the industry. 

Oral generic drugs are the leading delivery type of the product in the industry. 

The retail pharmacies account for the largest market share, among other distribution channels in the industry.

The leading players in the industry are Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., and Fresenius Kabi AG, among others.

Analyst Review

The global generic drugs market attained a value of USD 370 billion in 2020, driven by the rising cardiometabolic risk factors. Aided by the favourable initiatives undertaken by the governments, the industry is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 5.5%. The industry is projected to reach USD 510.2 billion by 2026.
 
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its applications, the market can be segmented into CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, and oncology, among others, with cardiovascular accounting for the largest market share. By drug delivery, the industry is led by oral generic drugs. On the basis of distribution channels, the global industry is led by retail pharmacies. The major regional markets are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above industry include Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., and Fresenius Kabi AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.  

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

United States Compounding Pharmacies Market Report and Forecast 2021-2026


Global Anaesthesia Drugs Market Report and Forecast 2021-2026


United States HIV Drugs Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Nootropics Market Report and Forecast 2021-2026


NEWSLETTER